Shadowfax Technologies Grants 780,424 Stock Options Under ESOP Plan
Shadowfax Technologies Ltd has announced the grant of stock options to eligible employees under its Employee Stock Option Plan 2016 (SFX ESOP 2016). The Nomination and Remuneration Committee (NRC) of the company granted a total of 7,80,424 stock options, effective from July 01, 2026.The decision to grant the options was made by the NRC in accordance with the terms of the SFX ESOP 2016. Each option is set at an exercise price of Rs. 10/- per option and is convertible into one fully paid-up equity share, which also has a face value of Rs. 10/-.
Key terms related to the granted options were detailed in the supporting documents. The details provided indicate that while the company issued the grant, no options have been exercised as of this disclosure.
A significant term of the plan mandates that all options will vest after a minimum period of twelve months from the Grant Date. The vesting structure is dependent on time and/or performance criteria and is subject to the continued employment of the recipient.
Details regarding the stock option grant are summarized below:
| Particulars | Details |
|---|---|
| Total Options Granted | 7,80,424 Employee Stock Options |
| Exercise Price per Option | Rs. 10/- |
| Shares Covered by Options | 7,80,424 equity shares (face value Rs. 10/- each) |
| Vesting Requirement | Minimum period of 12 months from the Grant Date |
The terms governing the options are outlined in the SFX ESOP 2016. The company confirmed that all other elements, such as options exercised or money realized from exercise, were not applicable at the time of this grant announcement.
SHADOWFAX Stock Price Movement
Today, shares of Shadowfax Technologies Limited shed value, closing down 2.25% to settle at ₹230.48. The stock traded a volume of 1.23 million shares and touched an intraday low of ₹228.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.